All News
View More
Six jobs for AI in myeloma care, from Prerna Mewawalla, M.D.

Only 19% of community oncologists use AI predictive models. Prerna Mewawalla, M.D., outlines six ways AI can already help in myeloma care.

Vaccine schedule overhaul could put coverage at risk, state official says

Jamilia Sherls, DNP, says health systems should track vaccine coverage closely and look to AAP schedules if federal guidance isn't evidence-based.

Joshua Stott, Ph.D., discusses why ADHD mortality risk is modifiable

People with ADHD had a 70% higher risk of death from any cause in a 19-study meta-analysis, with excess deaths from suicide, injury and natural causes.

Bronchiectasis is more common in the U.S. than a decade ago, study finds

Bronchiectasis affected 221.6 per 100,000 people in the U.S. over five years, which is higher than earlier national estimates, according to a study published in CHEST.

Cepheid’s 13-pathogen respiratory PCR panel earns CE marking under EU IVDR

Cepheid’s Xpert Respiratory Panel, which tests one swab for nine viruses and four bacteria, is now certified for sale in Europe under the IVDR.

Low blood NAD levels track heart disease and hypertension, not aging

A study of 1,068 adults found whole-blood NAD fell in those with cardiovascular disease and hypertension but did not decline with age.

A new strategy for secondary stroke prevention gets boost from FDA approval

Adding Sunharbo (asundexian), a first-in-class factor XI inhibitor, to single or dual antiplatelet therapy reduces ischemic stroke risk without increasing the risk of major bleeding.

A conversation with Joshua Stott, Ph.D., and Lucy Corrigan about the 70% higher mortality risk associated with ADHD

In this discussion, University College London colleagues Joshua Stott, Ph.D., professor of aging and clinical psychology and research assistant Lucy Corrigan, who led the work while at the University of Liverpool, talk about their recent meta-analysis linking ADHD to a higher risk of death from all causes, including suicide, injury and natural causes.

New AASM guideline on shift work disorder leans on low-cost fixes, steers clinicians away from benzodiazepines

The American Academy of Sleep Medicine’s first update since 2007 favors generic drugs, caffeine, light and naps, and advises against benzodiazepines.

Advertisement
Advertisement

Official Media Partners